We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...
Roquefort Therapeutics PLC 27 September 2024 27 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Interim Results to 30 June 2024 Roquefort...
Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...
Roquefort Therapeutics PLC 23 September 2024 23 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Grant of Japan MK Cell Patent Roquefort Therapeutics...
Roquefort Therapeutics PLC 19 September 2024 19 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") STAT-6 siRNA Demonstrates Efficacy in Immunology ...
Roquefort Therapeutics PLC 02 September 2024 2 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Grant of MK Cell Patent & Licencing Update ...
Roquefort Therapeutics PLC 27 June 2024 27 June 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Results of AGM Roquefort Therapeutics (LSE:ROQ, OTCQB: ROQAF...
Roquefort Therapeutics PLC 20 June 2024 20 June 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics") Appointment of Broker Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.6 | 3.6 | 3.6 | 171398 | 3.6 | DE |
4 | 0 | 0 | 3.6 | 3.78 | 3.35 | 168049 | 3.57794235 | DE |
12 | -1.15 | -24.2105263158 | 4.75 | 4.95 | 3.35 | 255628 | 4.09410968 | DE |
26 | -3.4 | -48.5714285714 | 7 | 7 | 3.35 | 319847 | 4.4138274 | DE |
52 | -4.15 | -53.5483870968 | 7.75 | 9.25 | 3.35 | 249848 | 5.46248261 | DE |
156 | -8.9 | -71.2 | 12.5 | 12.5 | 3.35 | 252155 | 7.40162138 | DE |
260 | -2.4 | -40 | 6 | 13.5 | 3.35 | 220874 | 7.46454231 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions